Legal & General Group
TBIO

Legal & General Group’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Legal & General Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed -$4K – 3694
2022
Q1 		$4K Hold
40
– – ﹤0.01% 3526
2021
Q4 		$8K Hold
40
– – ﹤0.01% 3503
2021
Q3 		$8K Buy
+40
New +$10.2K ﹤0.01% 3462

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's TBIO Position: Q2 2022 in Review

Legal & General Group sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 40 shares — an estimated $4K sold.

Legal & General Group first reported a position in TBIO in Q3 2021 and held it in 3 quarters. The position peaked at $8K in Q4 2021. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • Legal & General Group reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 40 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $4K.
  • Legal & General Group first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Legal & General Group's Telesis Bio, Inc. Common Stock position peaked at $8K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.